Tao Li

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Yunlong Cao, Jing Wang, Fanchong Jian et al. · Nature · 2021 · 2.1K citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Clinical progression of patients with COVID-19 in Shanghai, China

Jun Chen, Tangkai Qi, Li Liu et al. · Journal of Infection · 2020 · 856 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +11

[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Jun Chen, Danping Liu, Li Liu et al. · PubMed · 2020 · 706 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

Qianqian Li, Jianhui Nie, Jiajing Wu et al. · Cell · 2021 · 402 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes

Michael D. Southall, Tao Li, Lera S. Gharibova et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 293 citations

Life Sciences, Dermatology, Pharmacology +16